Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials
References (51)
- et al.
Alpha-linolenic acid and eicosapentaenoic acid
Lancet
(1980) - et al.
Eicosapentaenoic acid reduces the progression of carotid intimamedia thickness in patients with type 2 diabetes
Atherosclerosis
(2007) - et al.
Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy
Am J Cardiol
(2008) - et al.
N-3 polyunsaturated fatty acids, fatal ischemic heart disease and non-fatal myocardial infarction in older adults. The cardiovascular health study
Am J Clin Nutr
(2003) - et al.
Meta-analysis of observational studies on fish intake and coronary heart disease
Am J Cardiol
(2004) - et al.
N-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review
Am J Clin Nutr
(2006) - et al.
N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials
Am J Med
(2002) - et al.
Cardiovascular effects of marine omega-3 fatty acids
Lancet
(2010) - et al.
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
Lancet
(2007) - et al.
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
Control Clin Trials
(1996)
Meta-analysis in clinical trials
Controlled Clinical Trials
(1986)
Controlled trial of fish oil for regression of human coronary atherosclerosis
J Am Coil Cardiol
(1995)
Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol
Am J Clin Nutr
(2001)
Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation. Results of the FORWARD (randomized trial to assess efficacy of PUFA for the maintenance of sinus rhythm in persistent atrial fibrillation) trial
J Am Coll Cardiol
(2013)
N-3 fatty acids in cardiovascular disease
N Engl J Med
(2011)
Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos
Lancet
(1971)
Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia
Am J Health Syst Pharm
(2007)
Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids
Nutr Rev
(2010)
Efficacy of omega-3 fatty acid supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the secondary prevention of cardiovascular disease
Arch Intern Med
(2012)
The inverse relation between fish consumption and 20-year mortality from coronary heart disease
N Engl J Med
(1985)
Fish consumption and the 30-year risk of fatal myocardial infarction
N Engl J Med
(1997)
Fish consumption and risk of sudden cardiac death
JAMA
(1998)
Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands
Am J Epidemiol
(2000)
Intake of fish and omega-3 fatty acids and risk of stroke in women
JAMA
(2001)
Blood levels of long-chain n-3 fatty acids and the risk of sudden death
N Engl J Med
(2002)
Cited by (132)
Quality and safety profiles of Chlamys farreri cultured in the Shandong peninsula: Analysis of nutritional content, flavor, and hazards
2023, Journal of Food Composition and AnalysisEvidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease
2021, Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and DiseaseA New Zealand green-lipped mussel oil-enriched high-fat diet exhibits beneficial effects on body weight and metabolism in mice
2021, British Journal of Nutrition
Copyright © 2013 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.